These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The hyperkinetic child syndrome and brain monoamines: pharmacology and therapeutic implications. Margolin DI J Clin Psychiatry; 1978 Feb; 39(2):120-3, 7-30. PubMed ID: 344302 [TBL] [Abstract][Full Text] [Related]
3. Central monoamines and hyperkinase of childhood. Shetty T; Chase TN Neurology; 1976 Oct; 26(10):1000-2. PubMed ID: 986582 [TBL] [Abstract][Full Text] [Related]
4. Different adaptive responses by rat striatal dopamine synthetic and receptor mechanisms after repeated treatment with d-amphetamine, methylphenidate and nomifensine. Algeri S; Brunello N; Vantini G Pharmacol Res Commun; 1980 Jul; 12(7):675-81. PubMed ID: 6105682 [No Abstract] [Full Text] [Related]
5. Genetic differences in brain dopamine receptors and amphetamine response: possible model for hyperkinetic children. Helmeste DM; Seeman P Prog Clin Biol Res; 1983; 135():401-3. PubMed ID: 6665015 [No Abstract] [Full Text] [Related]
6. Plasma d-amphetamine absorption and elimination in hyperactive children. Brown GL; Ebert MH; Hunt RD Psychopharmacol Bull; 1978 Jul; 14(3):33-5. PubMed ID: 674533 [No Abstract] [Full Text] [Related]
7. Chronic amphetamine administration and central dopamine receptor sensitivity [proceedings]. Jenner P; Marsden CD; Pycock CJ Br J Pharmacol; 1977 Sep; 61(1):142P. PubMed ID: 912190 [No Abstract] [Full Text] [Related]
8. Levoamphetamine and dextroamphetamine: differential effect on aggression and hyperkinesis in children and dogs. Arnold LE; Kirilcuk V; Corson SA; Corson EO Am J Psychiatry; 1973 Feb; 130(2):165-70. PubMed ID: 4568123 [No Abstract] [Full Text] [Related]
9. Analogs of SR-141716A (Rimonabant) alter d-amphetamine-evoked [3H] dopamine overflow from preloaded striatal slices and amphetamine-induced hyperactivity. Miller DK; Rodvelt KR; Constales C; Putnam WC Life Sci; 2007 Jun; 81(1):63-71. PubMed ID: 17532007 [TBL] [Abstract][Full Text] [Related]
10. Urinary MHPG excretion in the hyperactive child syndrome and the effects of dextroamphetamine [proceedings]. Shekim WO; Dekirmenjian H; Chapel JL Psychopharmacol Bull; 1978 Apr; 14(2):42-4. PubMed ID: 652929 [No Abstract] [Full Text] [Related]
11. Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate. Wagner GC; Ricaurte GA; Johanson CE; Schuster CR; Seiden LS Neurology; 1980 May; 30(5):547-50. PubMed ID: 6768005 [TBL] [Abstract][Full Text] [Related]
12. Dextroamphetamine: cognitive and behavioral effects in normal and hyperactive boys and normal adult males. Rapoport JL; Buchsbaum MS; Weingartner H Psychopharmacol Bull; 1980 Jan; 16(1):21-3. PubMed ID: 7360831 [No Abstract] [Full Text] [Related]
14. Images in neuroscience. SPECT imaging of synaptic dopamine. Laruelle M; Innis RB Am J Psychiatry; 1996 Oct; 153(10):1249. PubMed ID: 8831430 [No Abstract] [Full Text] [Related]
15. [The role of dopamine in the physiology and pathology of the basal ganglia]. Arushanian EB Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763 [No Abstract] [Full Text] [Related]
16. The effect of bradykinin on central dopamine receptors. Przesmycki K; Kleinrok Z Pol J Pharmacol Pharm; 1976; 28(6):673-8. PubMed ID: 1034925 [TBL] [Abstract][Full Text] [Related]
17. Amphetamine-induced stereotypy: reply to Rebec and Bashore. Kokkinidis L; Anisman H Psychol Bull; 1983 Mar; 93(2):368-72. PubMed ID: 6682558 [No Abstract] [Full Text] [Related]